Insulet | PODD - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 12.59B 1.43B 2026-06
Align Technology USD 1.06B 20M 2026-06
AtriCure USD 153.6M 12.4M 2026-06
Baxter International USD 2.96B 260M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Boston Scientific USD 5.44B 240M 2026-06
Cardinal Health USD 63.7B 2.8B 2026-06
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.31B 120M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Globus Medical USD 789.61M 29.76M 2026-06
ICU Medical USD 551.68M 25.91M 2026-06
Inogen USD 74.93M 504K 2024-09
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
J&J USD 25.31B 1.21B 2026-06
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 418.8M 36.9M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Solventum Corp USD 2.2B 190M 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teleflex USD 570.3M 22M 2026-06
West Pharmaceutical Services USD 872.3M 27.4M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06